Routine preoperative coagulation tests: an outdated practice?

British Journal of Anaesthesia

Volumn 106, Issue 1, 2011, Pages 1-3

  van Veen, J J ^a   Spahn, D R ^b   Makris, M ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; EDITORIAL; HUMAN; METHODOLOGY; PATIENT SELECTION; PREOPERATIVE CARE; UNNECESSARY PROCEDURE;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; HUMANS; PATIENT SELECTION; PREOPERATIVE CARE; UNNECESSARY PROCEDURES;

EID: 79952119120     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq357     Document Type: Editorial

References (18)

1. Fukutake, K, Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan. Semin Thromb Hemost 26 (2000), 29–32.
2. Smit, C, Rosendaal, FR, Varekamp, I, et al. Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972–85. Br Med J 298 (1989), 235–238.
3. Giannelli, F, Green, PM, Sommer, SS, et al. Haemophilia B: database of point mutations and short additions and deletions—eighth edition. Nucleic Acids Res 26 (1998), 265–268.
4. Bolton-Maggs, PH, Perry, DJ, Chalmers, EA, et al. The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 10 (2004), 593–628.
5. Asakai, R, Chung, DW, Davie, EW, Seligsohn, U, Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 325 (1991), 153–158.
6. Halbmayer, WM, Haushofer, A, Schon, R, et al. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 71 (1994), 68–72.
7. Halbmayer, WM, Haushofer, A, Radek, J, Schon, R, Deutsch, M, Fischer, M, Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery. Coron Artery Dis 5 (1994), 451–454.
8. Petri, M, Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 15 (2000), 145–151.
9. Sadler, JE, Mannucci, PM, Berntorp, E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 84 (2000), 160–174.
10. Chee, YL, Crawford, JC, Watson, HG, Greaves, M, Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 140 (2008), 496–504.
11. Segal, JB, Dzik, WH, Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45 (2005), 1413–1425.
12. Koscielny, J, Ziemer, S, Radtke, H, et al. A practical concept for preoperative identification for patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10 (2004), 195–204.
13. Sramek, A, Eikenboom, JC, Briet, E, Vandenbroucke, JP, Rosendaal, FR, Usefulness of patient interview in bleeding disorders. Arch Intern Med 155 (1995), 1409–1415.
14. Tosetto, A, Rodeghiero, F, Castaman, G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 4 (2006), 766–773.
15. Samama, MM, Martinoli, JL, LeFlem, L, et al. Assessment of laboratory assays to measure rivaroxaban—an oral, direct factor Xa inhibitor. Thromb Haemost 103 (2010), 815–825.
16. van Ryn, J, Stangier, J, Haertter, S, et al. Dabigatran etexilate—a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103 (2010), 1116–1127.
17. Lippi, G, Favaloro, EJ, Salvagno, GL, Franchini, M, Laboratory assessment and perioperative management of patients on antiplatelet therapy: from bench to bedside. Clin Chim Acta 405 (2009), 8–16.
18. Chassot, PG, Delabays, A, Spahn, DR, Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk for myocardial infarction. Br J Anaesth 99 (2007), 316–328.